Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Autor: Fernández-Miranda I; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Pedrosa L; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., González-Rincón J; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; CoE Data Intelligence, Fujitsu Technology Solutions S.A., Pozuelo de Alarcón, Madrid, Spain., Espinet B; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain; Department of Pathology, Hospital del Mar, Barcelona, Spain., de la Cruz Vicente F; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain., Climent F; Department of Pathology, Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain., Gómez S; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Royuela A; Biostatistics Unit, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA. CIBERESP, ISCIII. Madrid, Spain., Camacho FI; Department of Pathology, Hospital Universitario de Getafe, Madrid, Spain., Martín-Acosta P; Department of Pathology, Cancer Molecular Pathology Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Yanguas-Casás N; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain., Domínguez M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Méndez M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Colomo L; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Salar A; Department of Hematology, Hospital del Mar, Barcelona, Spain., Horcajo B; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., Navarro M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain., García-Cosío M; Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Piris-Villaespesa M; Department of Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Llanos M; Department of Oncology, Hospital Universitario de Canarias, Tenerife, Spain., García JF; Department of Pathology, Hospital MD Anderson Cancer Center, Madrid, Spain., Sequero S; Department of Oncology, Hospital Universitario San Cecilio, Granada, Spain., Mercadal S; Department of Hematology, ICO-Hospital Duran I Reynals, Barcelona, Spain., García-Hernández S; Department of Pathology, Hospital Universitario de Canarias, Tenerife, Spain., Navarro B; Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain., Mollejo M; Department of Pathology, Complejo Hospitalario de Toledo, Spain., Provencio M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain., Sánchez-Beato M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain. Electronic address: msbeato@idiphim.org.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Jul; Vol. 37 (7), pp. 100516. Date of Electronic Publication: 2024 May 17.

An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy.

Autor: Rodríguez M; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain.; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain., Alonso-Alonso R; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain.; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain., Fernández-Miranda I; Lymphoma Research Group IIS Puerta de Hierro-Segovia de Arana (IDIPHISA) Madrid Spain., Mondéjar R; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.; UGC Laboratorios Hospital Universitario Puerto Real Cádiz Spain., Cereceda L; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain.; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain., Tráscasa Á; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Antonio-Da Conceiçao A; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Borregón J; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Gato L; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Tomás-Roca L; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Bárcena C; Pathology Department Hospital Universitario Doce de Octubre Madrid Spain., Iglesias B; Pathology Department Hospital Álvaro Cunqueiro Vigo Spain., Climent F; Pathology Department Hospital Universitari de Bellvitge L'Hospitalet de Llobregat Barcelona Spain., González-Barca E; Haematology Department Institut Català d'Oncologia Hospital Duran i Reynals L'Hospitalet de Llobregat Barcelona Spain., Camacho FI; Pathology Department Hospital Universitario de Getafe Madrid Spain., Mayordomo É; Pathology Department Hospital Universitario y Politécnico La Fe Valencia Spain., Olmedilla G; Pathology Department Hospital Universitario La Paz Madrid Spain., Gómez-Prieto P; Haematology Department Hospital Universitario La Paz Madrid Spain., Castro Y; Pathology Department Hospital Universitario Príncipe de Asturias Madrid Spain., Serrano-López J; Experimental Hematology Laboratory IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Sánchez-García J; Haematology Department Hospital Universitario Reina Sofia Maimonides Biomedical Research Institute IMIBIC University of Córdoba Córdoba Spain., Montes-Moreno S; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.; Pathology Department Hospital Universitario Marqués de Valdecilla Santander Spain., García-Cosío M; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.; Pathology Department Hospital Universitario Ramón y Cajal Madrid Spain., Martín-Acosta P; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.; Pathology Department Hospital Universitario Puerta de Hierro Madrid Spain., García JF; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.; Pathology Department MD Anderson Cancer Center Madrid Spain., Planelles M; Pathology Department Hospital General Universitario de Alicante Alicante Spain., Quero C; Clinical Oncology Department Hospital General Universitario Virgen de la Victoria Complejo Hospital Costa del Sol Marbella (Málaga) Spain., Provencio M; Clinical Oncology Department IIS Puerta de Hierro-Segovia de Arana (IDIPHISA) Madrid Spain., Mahíllo-Fernández I; Department of Epidemiology IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Rodríguez-Pinilla SM; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain.; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain., Derenzini E; Divisions of Haemato-Oncology and Haematopathology IEO European Institute of Oncology IRCCS Milan Italy., Pileri S; Divisions of Haemato-Oncology and Haematopathology IEO European Institute of Oncology IRCCS Milan Italy., Sánchez-Beato M; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.; Haematology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Córdoba R; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.; Haematology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain., Piris MA; Pathology Department IIS Hospital Universitario Fundación Jiménez Díaz Madrid Spain.; Center for Biomedical Network Research on Cancer (CIBERONC) ISCIII Madrid Spain.

Publikováno v: EJHaem [EJHaem] 2022 May 03; Vol. 3 (3), pp. 722-733. Date of Electronic Publication: 2022 May 03 (Print Publication: 2022).

Epstein-Barr virus-associated large B-cell lymphoma transformation in marginal zone B-cell lymphoma: a series of four cases.

Autor: Camacho Castañeda FI; Pathology Department, Hospital Universitario de Getafe, Madrid, Spain., Dotor A; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Manso R; Pathology Department, Madrid, Spain., Martín P; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Prieto Pareja E; Haematology Department, Fundación Jiménez Díaz, Madrid, Spain., Palomo Esteban T; Haematology Department, Fundación Jiménez Díaz, Madrid, Spain., García Vela JA; Haematology Department, Hospital Universitario de Getafe, Madrid, Spain., Santonja C; Pathology Department, Madrid, Spain., Piris MA; Pathology Department, Madrid, Spain., Rodríguez Pinilla SM; Pathology Department, Madrid, Spain.

Publikováno v: Histopathology [Histopathology] 2020 Jul; Vol. 77 (1), pp. 112-122. Date of Electronic Publication: 2020 Jun 12.

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.

Autor: González-Rincón J; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain., Méndez M; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Gómez S; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., García JF; Pathology Department, Hospital MD Anderson Cancer Center, Madrid, Spain., Martín P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Bellas C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Pedrosa L; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., Rodríguez-Pinilla SM; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain., Camacho FI; Pathology Department, Hospital Universitario de Getafe, Madrid, Spain., Quero C; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Malaga, Spain., Pérez-Callejo D; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Rueda A; Medical Oncology Department, Hospital Costa del Sol, Malaga, Spain., Llanos M; Medical Oncology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Gómez-Codina J; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Piris MA; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department, Fundación Jiménez Díaz, Madrid, Spain., Montes-Moreno S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.; Pathology Department/Translational Hematology Group, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain., Bárcena C; Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Rodríguez-Abreu D; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canarias, Spain., Menárguez J; Pathology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., de la Cruz-Merino L; Medical Oncology Department Hospital Universitario Virgen Macarena, Seville, Spain., Monsalvo S; Hematology Department, Fundación Jiménez Díaz, Madrid, Spain., Parejo C; TIC Unit- Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro- Segovia de Arana, Madrid, Spain., Royuela A; Clinical Biostatistics Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain., Kwee I; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Dalle Molle Institute for Artificial Intelligence (IDSIA), Belinzona, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland., Cascione L; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland.; Oncology Institute of Southern Switzerland (IOSI), Belinzona, Switzerland., Arribas A; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland.; Oncology Institute of Southern Switzerland (IOSI), Belinzona, Switzerland., Bertoni F; Institute of Oncology Research (IOR), Belinzona, Switzerland.; Universitá della Svizzera Italiana (USI), Lugano, Switzerland.; Swiss Institute of Bioinformatics (SIB), Belinzona, Switzerland.; Oncology Institute of Southern Switzerland (IOSI), Belinzona, Switzerland., Mollejo M; Pathology Department, Hospital Virgen de la Salud, Toledo, Spain., Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain., Sánchez-Beato M; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.

Publikováno v: PloS one [PLoS One] 2019 Feb 25; Vol. 14 (2), pp. e0212813. Date of Electronic Publication: 2019 Feb 25 (Print Publication: 2019).

[Polymyositis secondary to a non-Hodgkin's lymphoma].

Autor: Gil-Moreno MJ; Hospital Universitario de Getafe, 28905 Getafe, Espana., Escolar E; Hospital Universitario de Getafe, 28905 Getafe, Espana., Marasescu R; Hospital Universitario de Getafe, 28905 Getafe, Espana., Camacho-Castaneda FI; Hospital Universitario de Getafe, 28905 Getafe, Espana., Benito-Parra L; Hospital Universitario de Getafe, 28905 Getafe, Espana.

Publikováno v: Revista de neurologia [Rev Neurol] 2017 Apr 01; Vol. 64 (7), pp. 334-336.